CHROMagar Y.enterocolitica for detection and differentiation of pathogenic Yersinia enterocolitica strains
CHROMagar has launched an updated version of CHROMagar Y.enterocolitica, with improved selectivity and sensitivity, allowing laboratories to concentrate their efforts and resources only on suspect colonies that have a real potential of pathogenicity.
As with the previous version, pathogenic strains are immediately differentiated from non-pathogenic Yersinia enterocolitica and other bacteria by a distinctive mauve colony colour. There is, however, a reduction in the accompanying flora, facilitating the visualisation of mauve colonies.
The sensitivity has also been increased, with the product now able to better detect some rare biotype 4 serotype O3 strains that didn’t grow as well in the old version.
Phone: 02 9798 9066
Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research
Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...
TopoGEN Topoisomerase Assay Kits
TopoGEN provides innovative reagents and kits for topoisomerase research and mechanism-based drug...
Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis
The multiplex panel encompasses a wide selection of proteins essential for studying key...
